I have one observation on this. We're talking about why CAMR is not working. Mr. Kay has come up with an example, where a country that appears to have a substantial need for a product is not even willing to identify itself to avail itself of a low-cost generic.
I think it highlights a broader problem, which is the true desire of these countries to deal with HIV. If they're not even willing to be named to deal with their patients and the 300,000 children who are dying, it's a real problem.